Biotech

Provectus Biopharmaceuticals Inc. (NYSEMKT:PVCT) announced the initiation of a protocol titled “A Phase 1 Study to Assess the Safety, Tolerability and Effectiveness of PV-10 Chemoablation of Neuroendocrine Tumours (NET) Metastatic to the Liver in the Reduction of Biochemical Markers and Symptoms Caused by Secretory Products.”

Provectus Biopharmaceuticals Inc. (NYSEMKT:PVCT) announced the initiation of a protocol titled “A Phase 1 Study to Assess the Safety, Tolerability and Effectiveness of PV-10 Chemoablation of Neuroendocrine Tumours (NET) Metastatic to the Liver in the Reduction of Biochemical Markers and Symptoms Caused by Secretory Products.”
As quoted in the press release:

The 12-patient phase 1 study will run up to 48 months with interim data anticipated at the half-way point of the two-cohort study. Patients in the first of the two successive cohorts will receive PV-10 to a single NET tumor in their liver, while patients in the second cohort may receive PV-10 to multiple NET tumors.
Timothy Price, M.D. will serve as principal investigator for the study at The Queen Elizabeth Hospital in Woodville, South Australia.

Dr. Price explained:

The primary endpoint of our study will be assessment of safety and tolerability of PV-10 in the treatment of these metastatic NETs. Our secondary endpoints address preliminary efficacy, disease symptoms and biomarkers, and include assessments of Objective Response Rate (ORR) of injected and uninjected tumors; change in tumor biomarkers (somatostatin receptor expression, chromogranin A and 5-hydroxyindole acetic acid); change in NET symptoms assessed by standard quality of life instruments; and possible change in peripheral blood mononuclear cells (PBMCs).

Click here to read the full Provectus Biopharmaceuticals Inc. (NYSEMKT:PVCT) press release.

Featured

MARKETS

Markets
TSX19699.05-138.20
TSXV667.25-33.65
DOW31730.30-103.81
S&P 5003930.08-5.10
NASD11370.96+6.73
ASX6941.00-123.70

COMMODITIES

Commodities
Gold1823.94+3.46
Silver20.89+0.08
Copper4.09-0.01
Palladium1939.50+6.50
Platinum956.00+9.00
Oil107.59+1.46
Heating Oil3.76+0.02
Natural Gas7.78+0.04

DOWNLOAD FREE REPORTS

×